Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9462429rdf:typepubmed:Citationlld:pubmed
pubmed-article:9462429lifeskim:mentionsumls-concept:C1257890lld:lifeskim
pubmed-article:9462429lifeskim:mentionsumls-concept:C0315260lld:lifeskim
pubmed-article:9462429lifeskim:mentionsumls-concept:C0080194lld:lifeskim
pubmed-article:9462429lifeskim:mentionsumls-concept:C0597979lld:lifeskim
pubmed-article:9462429lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:9462429lifeskim:mentionsumls-concept:C0002518lld:lifeskim
pubmed-article:9462429lifeskim:mentionsumls-concept:C1880022lld:lifeskim
pubmed-article:9462429pubmed:issue6lld:pubmed
pubmed-article:9462429pubmed:dateCreated1998-3-12lld:pubmed
pubmed-article:9462429pubmed:abstractTextKlebsiella oxytoca strain HB60 is highly resistant to cefoperazone and aztreonam (MICs = 128 mg/L). It produces a chromosomally encoded beta-lactamase of pI 5.7 which was highly efficient against penicillins, first-generation cephalosporins and cefoperazone, a non-oxyimino third-generation cephalosporin. Aztreonam and oxyimino broad-spectrum cephalosporins were less good substrates. The beta-lactamase activity was susceptible to inhibition by clavulanic acid (IC50 = 1 microM). The enzyme purified to homogeneity had a specific activity towards benzylpenicillin of 3670 U/mg. The 263 amino acid residues of the protein were sequenced by Edman degradation of proteolytic peptides. The beta-lactamase was shown to belong to the OXY-2 group as it had only one amino acid substitution (Asn for Asp at ABL position 197) compared with the beta-lactamase (pI 5.2) from the aztreonam-susceptible K. oxytoca strain SL911 and two substitutions (Ala223 for Val and Asp255 for Asn) compared with the beta-lactamase (pI 6.4) from the aztreonam-resistant K. oxytoca strain D488. These three OXY-2-group enzymes behave in the same way towards beta-lactam antibiotics. The variability in the resistance of these K. oxytoca strains would thus seem to be due to variation in the level of production of the beta-lactamases rather than to structural alteration of the enzymes.lld:pubmed
pubmed-article:9462429pubmed:languageenglld:pubmed
pubmed-article:9462429pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9462429pubmed:citationSubsetIMlld:pubmed
pubmed-article:9462429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9462429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9462429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9462429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9462429pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9462429pubmed:statusMEDLINElld:pubmed
pubmed-article:9462429pubmed:monthDeclld:pubmed
pubmed-article:9462429pubmed:issn0305-7453lld:pubmed
pubmed-article:9462429pubmed:authorpubmed-author:BarthélémyMMlld:pubmed
pubmed-article:9462429pubmed:authorpubmed-author:LabiaRRlld:pubmed
pubmed-article:9462429pubmed:authorpubmed-author:SofenHHlld:pubmed
pubmed-article:9462429pubmed:authorpubmed-author:ReynaudAAlld:pubmed
pubmed-article:9462429pubmed:authorpubmed-author:PéduzziJJlld:pubmed
pubmed-article:9462429pubmed:authorpubmed-author:FarzanehSSlld:pubmed
pubmed-article:9462429pubmed:issnTypePrintlld:pubmed
pubmed-article:9462429pubmed:volume40lld:pubmed
pubmed-article:9462429pubmed:ownerNLMlld:pubmed
pubmed-article:9462429pubmed:authorsCompleteYlld:pubmed
pubmed-article:9462429pubmed:pagination789-95lld:pubmed
pubmed-article:9462429pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:9462429pubmed:meshHeadingpubmed-meshheading:9462429-...lld:pubmed
pubmed-article:9462429pubmed:meshHeadingpubmed-meshheading:9462429-...lld:pubmed
pubmed-article:9462429pubmed:meshHeadingpubmed-meshheading:9462429-...lld:pubmed
pubmed-article:9462429pubmed:meshHeadingpubmed-meshheading:9462429-...lld:pubmed
pubmed-article:9462429pubmed:meshHeadingpubmed-meshheading:9462429-...lld:pubmed
pubmed-article:9462429pubmed:meshHeadingpubmed-meshheading:9462429-...lld:pubmed
pubmed-article:9462429pubmed:meshHeadingpubmed-meshheading:9462429-...lld:pubmed
pubmed-article:9462429pubmed:meshHeadingpubmed-meshheading:9462429-...lld:pubmed
pubmed-article:9462429pubmed:meshHeadingpubmed-meshheading:9462429-...lld:pubmed
pubmed-article:9462429pubmed:meshHeadingpubmed-meshheading:9462429-...lld:pubmed
pubmed-article:9462429pubmed:year1997lld:pubmed
pubmed-article:9462429pubmed:articleTitleCharacterization and amino acid sequence of the OXY-2 group beta-lactamase of pI 5.7 isolated from aztreonam-resistant Klebsiella oxytoca strain HB60.lld:pubmed
pubmed-article:9462429pubmed:affiliationLaboratoire de Chimie, URA 401, IFR 63 CNRS, Muséum National d'Histoire Naturelle, Paris, France.lld:pubmed
pubmed-article:9462429pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:9462429pubmed:publicationTypeComparative Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9462429lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9462429lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9462429lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:9462429lld:pubmed